We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
FDA newcomer Gerald Masoudi took over as the FDA’s acting chief counsel Nov. 28, replacing Daniel Troy, who announced Nov. 16 that he was leaving the agency.
Generic Line interviewd Ajaz Hussain, deputy director of the Office of Pharmaceutical Science (OPS) in the Center for Drug Evaluation and Research, FDA.
The U.S. Justice Department has initiated a criminal investigation of Merck related to the firm’s controversial arthritis drug Vioxx, the company revealed in a recent filing with the Securities and Exchange Commission (SEC).
Generic Line interviewed Bruce Downey, chairman and CEO of Barr Pharmaceuticals, a specialty company engaged in the development, manufacture, and marketing of proprietary and generic prescription pharmaceuticals.